Can an Active App Improve Fitness With Sleep Apnea?

Your sleep tracker can tell you that you slept badly and walked 3,842 steps. That information may be useful. But in obstructive sleep apnea (OSA), tracking alone has not improved physical activity or cardiorespiratory fitness in controlled studies. A 2026 systematic review found benefits only when digital programs asked patients to do something with the data: follow goals, receive performance-based feedback, and use structured behavior-change tools.

The distinction matters because CPAP treats airway obstruction, but it does not appear to restore exercise capacity by itself. For people with OSA, a wearable is measurement. A program that turns measurement into a tailored exercise plan may be part of treatment.

Passive tracking did not improve fitness

Xia et al.'s 2026 systematic review and meta-analysis pooled randomized and controlled trials of digital health technologies in people with OSA. The review separated active interventions from passive monitoring. Active programs included structured components such as goal-setting, real-time closed-loop feedback, and formal behavior-change techniques. Passive arms used wearables or apps without structured behavioral engagement.

Only the active interventions improved objective step counts, with a reported P value of 0.02, and cardiorespiratory fitness. The pooled mean difference in VO₂max was 342 mL/min in favor of active digital interventions. Passive monitoring had null effects across the measured outcomes.

The available publication details do not provide the confidence interval around that VO₂max estimate, the number of participants, heterogeneity statistics, or usable subgroup analyses. Those omissions limit precision. Still, the review's main finding is more useful than the usual promise that "digital health works": the successful programs did more than display data.

A 342 mL/min increase could be clinically meaningful, though its meaning depends on body size. For an 80 kg adult, it is roughly 1.2 metabolic equivalents, using the conventional estimate that one MET equals about 3.5 mL/kg/min. Many people with OSA weigh more than 80 kg, so the same absolute improvement would translate to fewer METs per kilogram.

CPAP and exercise support different jobs

CPAP remains first-line treatment for OSA because it prevents repeated airway collapse during sleep. The Xia review reports that CPAP alone did not improve VO₂max. That does not make CPAP optional; it means airway treatment and physical reconditioning address different problems.

An active digital program could therefore complement CPAP rather than replace it. CPAP targets sleep-disordered breathing. A goal-driven program may help break the sedentary patterns and deconditioning that often persist after treatment begins. No evidence here shows that the combination reduces cardiovascular events, and no trial establishes whether the two treatments are additive or synergistic for long-term clinical outcomes.

What makes a digital intervention active?

The OSA review cannot identify one winning app feature with confidence. Behavior-change techniques were not reported consistently enough across related exercise research to rank individual components. But the broader pattern supports active engagement over self-monitoring alone.

In a 2024 systematic review and meta-analysis in cancer survivors, mobile-health programs improved cardiorespiratory fitness when they delivered structured exercise prescriptions; passive tracking was insufficient. A 2022 systematic review of mobile activity programs for midlife women similarly identified personalized feedback and goal-setting as the features associated with better physical-activity outcomes.

These studies involve different populations, so they do not prove that the same components cause the OSA effect. They do, however, make the central idea plausible: information works better when it leads to a specific target, an action plan, and feedback tied to actual behavior. A step-count dashboard without those features is closer to a bathroom scale than a coach.

There is a caution. A 2021 systematic review in COPD found limited evidence that exercise training reduced sedentary time, and trial reports often described behavior-change techniques poorly. That reporting problem complicates claims about mechanism. A successful trial may contain useful behavioral features that authors never named; a supposedly passive program may include informal coaching. The outcome-level distinction in OSA has evidence behind it. The exact recipe does not.

Fitness matters, but mortality claims go too far

Cardiorespiratory fitness is a meaningful outcome in a population with high rates of hypertension, metabolic disease, and cardiovascular comorbidity. In people with established cardiovascular disease, a 2022 systematic review and meta-analysis found that fitness measured by cardiopulmonary exercise testing was independently and inversely associated with all-cause and cardiovascular mortality. A 2021 meta-analysis found that estimated fitness predicted cardiovascular and all-cause mortality as well.

The association also appears in cardiometabolic populations. A 2022 cohort study in adults with overweight or obesity and type 2 diabetes found that baseline cardiorespiratory fitness predicted mortality and cardiovascular events independently of BMI. A 2025 prospective Copenhagen cohort found cardiorespiratory fitness was a stronger independent predictor of all-cause and cardiovascular mortality than muscle strength.

Those results make improved VO₂max worth pursuing. They do not show that raising VO₂max by 342 mL/min with an app reduces mortality in OSA. The mortality studies measured baseline fitness, not fitness gains caused by an intervention. Sicker people may begin with lower fitness and also face greater mortality risk because of their illness. A 2021 review in adults with cancer describes this reverse-causation problem directly.

Exercise training can improve risk markers without proving fewer heart attacks or longer life. A 2023 meta-analysis found that high-intensity interval training improved central blood pressure, while a 2026 Cochrane review reported improved cardiometabolic syndrome risk markers in healthy sedentary adults. Neither study tested people with OSA, and neither converts a change in VO₂max into a guaranteed outcome benefit.

The unresolved question is whether people keep the gains

Digital programs can work while people use them. Whether they keep working after the notifications stop is less certain. In cancer survivors, the cardiorespiratory-fitness effects of mobile-health exercise programs attenuated at longer follow-up after the program ended. The OSA review does not provide extractable 6- to 12-month post-intervention step-count or VO₂max results.

That gap has practical consequences. If activity and fitness decline after the program ends, an active app may need a maintenance plan: ongoing goals, periodic coaching, or a transition to a sustainable exercise routine. The evidence does not yet tell us which approach works best, whether OSA severity changes response, or whether people with mild, moderate, and severe apnea benefit equally.

For OSA, choose a digital program that prescribes action and responds to performance—not one that merely records it. Keep using CPAP as prescribed, and treat improved fitness as a valuable goal rather than proof of reduced cardiovascular risk.

The current evidence supports CPAP plus an active, behavior-focused digital intervention for patients who want help increasing activity and fitness. It does not support swapping CPAP for an app, or expecting a passive tracker to do the behavioral work for you.